BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 22642135)

  • 1. [Myasthenia--ocular type].
    Stefanescu AM; Ungureanu E; Tugui A; Gradinaru SL
    Oftalmologia; 2011; 55(4):40-6. PubMed ID: 22642135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Internuclear bilateral pseudo-ophthalmoplegia and dermatomyositis].
    Ehongo A; Cordonnier M; Van Nechel C; Thibaut S; Collier A; Brucher JM; Monseu G
    Bull Soc Belge Ophtalmol; 1996; 263():43-51. PubMed ID: 9410406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatment.
    Kupersmith MJ; Ying G
    Br J Ophthalmol; 2005 Oct; 89(10):1330-4. PubMed ID: 16170126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ocular myasthenia gravis in an academic neuro-ophthalmology clinic: clinical features and therapeutic response.
    Mittal MK; Barohn RJ; Pasnoor M; McVey A; Herbelin L; Whittaker T; Dimachkie M
    J Clin Neuromuscul Dis; 2011 Sep; 13(1):46-52. PubMed ID: 22361625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Childhood myasthenia gravis: clinical features and outcomes.
    Sri-udomkajorn S; Panichai P; Liumsuwan S
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S152-7. PubMed ID: 22043769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double seronegative myasthenia gravis with low density lipoprotein-4 (LRP4) antibodies presenting with isolated ocular symptoms.
    Tsivgoulis G; Dervenoulas G; Kokotis P; Zompola C; Tzartos JS; Tzartos SJ; Voumvourakis KI
    J Neurol Sci; 2014 Nov; 346(1-2):328-30. PubMed ID: 25248951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charcot-Marie-Tooth disease mimicking ocular myasthenia gravis.
    Spector RH; Smith JL; Chavis PS
    Ann Ophthalmol; 1978 Aug; 10(8):1033-8. PubMed ID: 697278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic yields and clinical features of ocular myasthenia gravis.
    Kim H; Oh SY
    Medicine (Baltimore); 2021 Jun; 100(25):e26457. PubMed ID: 34160444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Ocular symptoms in myastenia gravis pseudoparalytica with special reference to the external eye muscles].
    Lahl R; Remus I
    Schweiz Arch Neurol Neurochir Psychiatr; 1973; 113(2):273-93. PubMed ID: 4776670
    [No Abstract]   [Full Text] [Related]  

  • 10. Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus.
    Appenzeller S; Veilleux M; Clarke A
    Lupus; 2009 Aug; 18(9):836-40. PubMed ID: 19578109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myasthenia gravis: an unusual cause of diplopia in polymyalgia rheumatica.
    Fernández-Castro M; Andreu JL; Muñoz P; Ornilla E
    Clin Exp Rheumatol; 2004; 22(4):505. PubMed ID: 15301257
    [No Abstract]   [Full Text] [Related]  

  • 12. Oral corticosteroids in the treatment of ocular myasthenia gravis.
    Fischer KC; Schwartzmann RJ
    Neurology; 1974 Aug; 24(8):795-8. PubMed ID: 4858423
    [No Abstract]   [Full Text] [Related]  

  • 13. Visual and systemic outcomes in pediatric ocular myasthenia gravis.
    Pineles SL; Avery RA; Moss HE; Finkel R; Blinman T; Kaiser L; Liu GT
    Am J Ophthalmol; 2010 Oct; 150(4):453-459.e3. PubMed ID: 20678749
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successive yet distinct episodes of isolated ophthalmoplegia associated with anti-GQ1b antibody.
    Cardenas D; Mishra SK; Ohanian AG; Ovbiagele B
    Neurology; 2005 Jul; 65(1):163. PubMed ID: 16009911
    [No Abstract]   [Full Text] [Related]  

  • 15. [Ocular myasthenia].
    Huber A
    Klin Monbl Augenheilkd; 1985 Mar; 186(3):158-60. PubMed ID: 3999598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-up.
    Kupersmith MJ
    J Neurol; 2009 Aug; 256(8):1314-20. PubMed ID: 19377863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ice pack test in the differential diagnosis of myasthenic diplopia.
    Chatzistefanou KI; Kouris T; Iliakis E; Piaditis G; Tagaris G; Katsikeris N; Kaltsas G; Apostolopoulos M
    Ophthalmology; 2009 Nov; 116(11):2236-43. PubMed ID: 19744729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myasthenia gravis and the Miller-Fisher variant of Guillain-Barré syndrome.
    Newsom-Davis J
    Curr Opin Neurol; 1997 Feb; 10(1):18-21. PubMed ID: 9099522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electromyography in neurogenic and pseudoneurogenic disorders of ocular motility. IV. Characteristics of ocular myopathies--differential diagnosis].
    Wójtowicz S
    Klin Oczna; 1969; 39(3):423-30. PubMed ID: 5804963
    [No Abstract]   [Full Text] [Related]  

  • 20. [Ocular myasthenia: clinical course and strategies for treatment].
    Marzo ME; Pérez López-Fraile I; Capablo JL; Ara JR; Usón M
    Rev Neurol; 1998 Mar; 26(151):398-400. PubMed ID: 9585951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.